Skip to main content

MoneyWorks4Me

Accretion Nutraveda informs about disclosures

17 Feb 2026 Evaluate
Accretion Nutraveda has informed that The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Unicorn Fund.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1893.20
Dr. Reddys Labs. 1385.10
Cipla 1403.60
Lupin 2015.00
Zydus Lifesciences 1204.85
View more..